Home/ Supplements/ Vitamin A/ ProJoba Super Daily

ProJoba Super Daily

product on market Tablet or Pill ProJoba International Safety: 90/100
90/100

This product looks safe

  • Niacin: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)
  • Contains proprietary blend — exact ingredient amounts not disclosed
  • 54% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This product contains a blend of fat-soluble and antioxidant vitamins that support immune function, bone health, and cellular protection. There is strong evidence for the efficacy of these vitamins in maintaining general health. However, the overall evidence coverage for this specific formulation is limited.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Niacin: 50mg is 1.4× the Tolerable Upper Intake Level (35mg)

Contains proprietary blend — exact ingredient amounts not disclosed

Label

Product Label

Label for ProJoba Super Daily
Open Full PDF View on NIH DSLD →
Details

Label Data

3 Tablet(s)
Serving Size
30
Servings
Other Combinations
Product Type
54%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Vitamin A
10000 IU (200% DV)
Vitamin C
1000 mg (1667% DV)
400 IU (100% DV)
Within RDA (0.7× RDA) 608 studies (A:16, B:251)
400 IU (1333% DV)
17.9× RDA — above typical dose (UL: 1000 mg) 179 studies (A:3, B:90)
100 mcg (125% DV)
Within RDA (0.8× RDA) 275 studies (A:9, B:175)
50 mg (3333% DV)
41.7× RDA — above typical dose 76 studies (A:0, B:33)
50 mg (2941% DV)
38.5× RDA — above typical dose 13 studies (A:0, B:1)
50 mg (250% DV)
Exceeds UL by 1.4× (UL: 35 mg) 196 studies (A:5, B:63)
50 mg (2500% DV)
38.5× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
400 mcg (100% DV)
Within RDA (1.0× RDA) 226 studies (A:10, B:105)
100 mcg (1667% DV)
41.7× RDA — above typical dose 139 studies (A:1, B:44)
100 mcg (33% DV)
3.3× RDA — above typical dose 27 studies (A:0, B:11)
50 mg (500% DV)
10.0× RDA — above typical dose 2 studies — no high-quality reviews
Calcium
500 mg (50% DV)
50 mg (5% DV)
Within RDA (0.1× RDA) 13 studies (A:0, B:3)
150 mcg (100% DV)
Within RDA (1.0× RDA) 245 studies (A:4, B:133)
250 mg (63% DV)
Within RDA (0.6× RDA) 316 studies (A:8, B:159)
15 mg (100% DV)
1.4× RDA — within safe limits 263 studies (A:6, B:134)
200 mcg (286% DV)
3.6× RDA — above typical dose (UL: 0.4 mg) 173 studies (A:0, B:67)
1 mg (50% DV)
1.1× RDA — within safe limits 37 studies (A:0, B:11)
5 mg (250% DV)
2.2× RDA — within safe limits 9 studies — no high-quality reviews
200 mcg (167% DV)
5.7× RDA — above typical dose 199 studies (A:1, B:55)
100 mcg (133% DV)
2.2× RDA — within safe limits 3 studies — no high-quality reviews
Potassium
50 mg (1% DV)
100 mg (3% DV)
Market median: 4002.0mg (1 products) 21 studies (A:0, B:2)
Vegetable Complex
250 mg
Fruit Complex
250 mg
250 mg
Market median: 200.0mg (107 products)
Market median: 500.0mg (283 products) 174 studies (A:0, B:62)
Acidophilus
25 mg
Market median: 60.0mg (94 products) 13 studies (A:0, B:7)
Mushroom Complex
30 mg
Market median: 500.0mg (9 products) 7 studies — no high-quality reviews
Hesperidin
25 mg
25 mg
Market median: 500.0mg (19 products)
5 mg
Market median: 500.0mg (283 products) 174 studies (A:0, B:62)
Apple Pectin
15 mg
RNA/DNA Complex
10 mg
50 mg
Within RDA (0.1× RDA) 38 studies (A:1, B:7)
50 mg
Market median: 550.0mg (217 products) 29 studies (A:0, B:5)
3 mg
Market median: 3.0mg (58 products) 3 studies — no high-quality reviews
1 mg
Market median: 10.0mg (105 products) 2 studies (A:0, B:1)
10 mg
Market median: 100.0mg (283 products) 144 studies (A:1, B:64)
Market median: 100.0mg (284 products) 10 studies (A:0, B:4)
Pine bark extract
25 mg
Market median: 260.0mg (249 products) 158 studies (A:4, B:61)
Barley Grass
30 mg
Market median: 450.0mg (390 products) 160 studies (A:0, B:63)
Market median: 450.0mg (390 products) 160 studies (A:0, B:63)
25 mg
Market median: 1000.0mg (212 products) 12 studies (A:0, B:3)
Oat Bran
25 mg
Digestive Enzyme Complex
110 mg
Proprietary Blend
30 mg
Market median: 100.0mg (120 products)
Gotu Kola
30 mg
Lecithin
25 mg
Yellow Dock
30 mg
30 mg
Market median: 500.0mg (497 products) 135 studies (A:0, B:40)
30 mg
Market median: 420.0mg (127 products) 4 studies (A:0, B:1)

Other Ingredients

Cellulose Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Additional Information

Dr. Joel Wallach, BS, Providing Innovative Since 1989

Food Based Vitamin/Mineral Complex

Item #: PJ220

Metadata

Product Details

DSLD Entry Date2012-10-01
Product TypeOther Combinations
FormTablet or Pill
DSLD ID12909
Data Updated2026-04-11
Research

Research Evidence

337
Research Sources
54
Avg Quality
161
Meta Analysis
68
Systematic Review
51
Rct
48
Clinical Trial
2
Other
2
Regulatory Source
1
Narrative Review
1
Cochrane Review
1
Guideline
1
Openfda Safety
A Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection
Meta Analysis The Cochrane database of systematic reviews 2011 PubMed DOI
A Vitamin A supplements for preventing mortality, illness, and blindness in children aged under 5: systematic review and meta-analysis
Meta Analysis BMJ (Clinical research ed.) 2011 PubMed DOI
A Fortification of staple foods with vitamin A for vitamin A deficiency
Systematic Review The Cochrane database of systematic reviews 2019 PubMed DOI
A Vitamin A supplementation for the prevention of morbidity and mortality in infants one to six months of age
Narrative Review The Cochrane database of systematic reviews 2016 PubMed DOI
A Vitamin A and fish oils for preventing the progression of retinitis pigmentosa
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Exercise training-induced changes in exerkine concentrations may be relevant to the metabolic control of type 2 diabetes mellitus patients: A systematic review and meta-analysis of randomized controlled trials
Meta Analysis Journal of sport and health science 2023 PubMed DOI
A Food fortification with multiple micronutrients: impact on health outcomes in general population
Meta Analysis The Cochrane database of systematic reviews 2019 PubMed DOI
A Oral vitamin A supplements to prevent acute upper respiratory tract infections in children up to seven years of age
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
View all evidence for Vitamin A →
Compare

Similar Products

View all Vitamin A products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.